32 results
management review diagnosis syndrome antibiotics neurology tb tuberculosis activetb covid19 criticalcare differential hivaids idsa infections medications opportunistic prevention prophylaxis table
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020 #Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... #Medications #Treatment ... #COVID19 #Pharmacology
Elagolix (Orilissa) - Pharmacology Review Elagolix is a small-molecule GnRH antagonist recently approved by the FDA for
Elagolix (Orilissa) - Pharmacology ... the FDA for the treatment ... #Pharmacology #Elagolix ... Orilissa #Review #Overview
Alprazolam - short-acting benzodiazepine (GABA Receptor Modulator) used in the treatment of anxiety disorders. FDA approved
Modulator) used in the treatment ... #Pharmacology #Alprazolam ... #Xanax #Overview
Metformin - oral antihyperglycemic agent for treatement of type II diabetes. 8th most prescribed drug in
antihyperglycemic agent for treatement ... #Pharmacology #Metformin ... Fortamet #AMPK #Overview
Migraine Treatment Overview • What is a Migraine? • Pathophysiology • Common Migraine Triggers • Diagnosis
Migraine Treatment ... Overview • ... • Pathophysiology ... Prophylactic Treatment ... #management #pharmacology
Amlodipine - calcium channel blocker for the treatment of hypertension and CAD. 5th most prescribed drug
blocker for the treatment ... #Pharmacology #Amlodipine ... CalciumChannelBlocker #CCB #Overview
Lisinopril - ACE inhibitor used for the treatment of hypertension and heart failure. 3rd most prescribed
inhibitor used for the treatment ... #Pharmacology #Lisinopril ... AngiotensinConvertingEnzyme #Inhibitor #Overview
Initial treatment of renal bone disease and cinacalcet for secondary hyperparathyroidism Phosphate binders reduce hyperphosphataemia and hyperparathyroidism.
Initial treatment ... the first-line treatments ... #Pharmacology #Pathophysiology
â–º
 Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... tuberculosis (LTBI) Pathophysiology ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... tuberculosis (LTBI) Pathophysiology ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
No results found for "Dashboard pharmacology pathophysiology overview treatment latenttb"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Dashboard #pharmacology #pathophysiology #overview #treatment #latenttb